The FTC is investigating Stryker’s proposed purchase of Wright Medical Group to determine if it is anticompetitive, according to Mass Device.
Stryker, a Fortune 500 medical devicemaker based in Kalamazoo, Mich., announced in November that it would acquire Memphis, Tenn.-based Wright Medical for a total enterprise value of $5.4 billion.
A Jan. 2 Securities and Exchange Commission filing from the FTC showed the agency sent second requests to both Stryker and Wright Medical to investigate the acquisition further.
Stryker plans to pay $30.75 per share for Wright Medical, according to Mass Device.
Read the full article here.